Compliance Online Webinars 2017 - Process Validation for Drugs and Biologics

Description:
This course will provide participants with a thorough understanding of the requirements of process validation for both small molecule (pharmaceuticals) and Biologic products. They will learn how to establish an effective process validation system and integrate it with other systems such as Risk Management, Corrective and Preventive Action and Supplier Management.
Participants will learn how to develop rigorous protocols and reports, as well as create monitoring programs to ensure that defined critical parameters remain in control. The course will also review validation requirements for systems that generate electronic signatures and records as most new processes have this capability.
Course Objective:
Upon completing this course participants should:
? Understand the new FDA perspective of a "Process Validation Life-Cycle" that starts at the Process Design phase (Process/Product Development) and continues through Process Qualification (Confirmation) and Continued Process Verification (Monitoring and Assessment of the process effectiveness) as stated by the FDA's new Guideline on Process Validation and its impact on how process validation activities are carried out
? Understand the perspective of the EMEA, ICH, WHO and PIC/S on process validation and how they can be incorporated into a single process validation system
? Be able to set up process validation programs and corresponding documentation including protocols and reports that meet current FDA, WHO, PIC/S and EU regulations
? Prepare and defend your own process validation approach/program and avoid costly delays and rejections by regulatory agencies
Course Outline:
I. Introduction to Process Validation
? Regulatory Perspective ? Biologics vs. Pharma
o Defining Validation
o Recognize the role process validation plays in understanding process and product variability ? Making the Validation Fit Your Product
o Types of Process Validation ? Retrospective ? Concurrent - Prospective
o Understand the perspectives of the FDA, international regulators and the GHTF
II. Implementing a Process Validation System
? Establishing the Infrastructure
o The process validation procedure
o Roles and responsibilities
o Equipment and facilities
? Process Validation Requirements
o Requirements of Title 21
o Review of the FDA Guidance on Process Validation
o Differences between Regulatory Agencies Requirements
? ICH
? EMEA
? PIC/S
III. Executing a Validation
? Other Related Components of Validation
o Facility Validations
o Cleaning Validations
o Processing Equipment Validations
o Viral Clearance Validation
o Sterilization Validation
o Packaging Validations
o Computer System Validation
IV. Supplier Process Validations
? Requirements of Suppliers
o Validation based on supplier criticality
o Role of Quality Agreement in Process Validation
o Communication of process changes
o Inspection vs Validation of supplied components
V. The Validation Life Cycle
? Re-validation
o When, why and what
o Handling problems during re-validation
o Product and process implications
? Product complaints and process failures
o Evaluating process parameters as a cause of product failures
o Process change history
o Amending the existing MVP
? Implementing the System
o Assessing the status of existing systems
o Identifying the systems to be validated
o Determining when revalidation is required
o Defining and controlling the Master Validation Plan (MVP)
o An audit perspective of the MVP
VI. Process Validation Compliance
? Avenues for Assessing Compliance
o Internal audits
o Complaints and corrective action
o Process changes
o Process FMEA
o Review of recent Warning Letters and Consent Decrees.